Literature DB >> 27932471

A Paradigm Shift Is Needed in the Field of Pulmonary Arterial Hypertension for Its Entrance Into the Precision Medicine Era.

Vikram Gurtu1, Evangelos D Michelakis2.   

Abstract

Entities:  

Keywords:  biomarkers; heart ventricles; hypertension, pulmonary; precision medicine; translational medical research

Mesh：

Year:  2016        PMID： 27932471     DOI： 10.1161/CIRCRESAHA.116.309689

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

1.  Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition.

Authors:  Sebastian Barreto Ortiz; Daijiro Hori; Yohei Nomura; Xin Yun; Haiyang Jiang; Hwanmee Yong; James Chen; Sam Paek; Deepesh Pandey; Gautam Sikka; Anil Bhatta; Andrew Gillard; Jochen Steppan; Jae Hyung Kim; Hideo Adachi; Viachaslau M Barodka; Lewis Romer; Steven S An; Larissa A Shimoda; Lakshmi Santhanam; Dan E Berkowitz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-07       Impact factor: 5.464

2.  Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension.

Authors:  Seungbum Kim; Katya Rigatto; Marcelo B Gazzana; Marli M Knorst; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Hypertension       Date:  2020-02-24       Impact factor: 10.190

3.  Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ravindra K Sharma; Aline C Oliveira; Tao Yang; Marianthi M Karas; Jing Li; Gilberto O Lobaton; Victor P Aquino; Iñaki Robles-Vera; Annette D de Kloet; Eric G Krause; Andrew J Bryant; Amrisha Verma; Qiuhong Li; Elaine M Richards; Mohan K Raizada
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

Review 4.  Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both.

Authors:  Jeffrey D Marshall; Isabel Bazan; Yi Zhang; Wassim H Fares; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

Review 5.  ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.

Authors:  Ravindra K Sharma; Bruce R Stevens; Alexander G Obukhov; Maria B Grant; Gavin Y Oudit; Qiuhong Li; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Hypertension       Date:  2020-08-12       Impact factor: 10.190

6.  Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension.

Authors:  Ravindra K Sharma; Aline C Oliveira; Seungbum Kim; Katya Rigatto; Jasenka Zubcevic; Anandharajan Rathinasabapathy; Ashok Kumar; Joseph J Lebowitz; Habibeh Khoshbouei; Gilberto Lobaton; Victor Aquino; Elaine M Richards; Michael J Katovich; Vinayak Shenoy; Mohan K Raizada
Journal:  Hypertension       Date:  2018-04-30       Impact factor: 10.190

7.  Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model.

Authors:  Hyun-Wook Lee; Sung-Hyun Park
Journal:  Oncotarget       Date:  2017-05-30

8.  Hypoxia Triggers SENP1 (Sentrin-Specific Protease 1) Modulation of KLF15 (Kruppel-Like Factor 15) and Transcriptional Regulation of Arg2 (Arginase 2) in Pulmonary Endothelium.

Authors:  Deepesh Pandey; Yohei Nomura; Max C Rossberg; Daijiro Hori; Anil Bhatta; Gizem Keceli; Thorsten Leucker; Lakshmi Santhanam; Larissa A Shimoda; Dan Berkowitz; Lewis Romer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-22       Impact factor: 8.311

9.  Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.

Authors:  Fotios Spyropoulos; Zoe Michael; Benjamin Finander; Sally Vitali; Kosmas Kosmas; Panagiotis Zymaris; Brian T Kalish; Stella Kourembanas; Helen Christou
Journal:  Front Cardiovasc Med       Date:  2021-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.